These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29314615)

  • 1. Serum prolactin levels might become a useful marker for switching strategy to paliperidone palmitate in male schizophrenia patient.
    Nakamura M; Fujita Y; Nagamine T
    Asia Pac Psychiatry; 2018 Mar; 10(1):. PubMed ID: 29314615
    [No Abstract]   [Full Text] [Related]  

  • 2. Add-on effects of a low-dose aripiprazole in resolving hyperprolactinemia induced by risperidone or paliperidone.
    Qiao Y; Yang F; Li C; Guo Q; Wen H; Zhu S; Ouyang Q; Shen W; Sheng J
    Psychiatry Res; 2016 Mar; 237():83-9. PubMed ID: 26921057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Switching from oral atypical antipsychotic monotherapy to paliperidone palmitate once-monthly in non-acute patients with schizophrenia: A prospective, open-label, interventional study.
    Schreiner A; Caspi A; Bergmans P; Cherubin P; Keim S; Lara E; Pinchuk I; Schuepbach D; Suleman S; Hargarter L
    Psychopharmacology (Berl); 2017 Jan; 234(1):3-13. PubMed ID: 27815602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced sexual dysfunction with aripiprazole once-monthly versus paliperidone palmitate: results from QUALIFY.
    Potkin SG; Loze JY; Forray C; Baker RA; Sapin C; Peters-Strickland T; Beillat M; Nylander AG; Hertel P; Steen Andersen H; Eramo A; Hansen K; Naber D
    Int Clin Psychopharmacol; 2017 May; 32(3):147-154. PubMed ID: 28252452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessments of plasma concentrations, pathology symptoms, and cognition following paliperidone treatment in schizophrenic patients previously treated with risperidone.
    Suzuki H; Gen K; Inoue Y; Hibino H; Mikami A; Matsumoto H; Mikami K
    Asian J Psychiatr; 2017 Apr; 26():56-57. PubMed ID: 28483092
    [No Abstract]   [Full Text] [Related]  

  • 6. Multidimensional Assessment of Functional Outcomes in Schizophrenia: Results From QUALIFY, a Head-to-Head Trial of Aripiprazole Once-Monthly and Paliperidone Palmitate.
    Potkin SG; Loze JY; Forray C; Baker RA; Sapin C; Peters-Strickland T; Beillat M; Nylander AG; Hertel P; Nitschky Schmidt S; Eramo A; Hansen K; Naber D
    Int J Neuropsychopharmacol; 2017 Jan; 20(1):40-49. PubMed ID: 27927736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined typical and atypical long-acting injectable antipsychotics in treatment-resistant schizophrenia: Two cases.
    Li FL; Yeh TC; Yang FC; Liang CS
    Psychiatry Clin Neurosci; 2019 Mar; 73(3):140. PubMed ID: 30474344
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cost-effectiveness analysis of aripiprazole once-monthly versus paliperidone palmitate once-monthly in the treatment of schizophrenia in France].
    Gozlan G; Lecardeur L; Monfort AS; Doz M; Ortiz I; Larroumets P; Lafuma A
    Encephale; 2018 Dec; 44(6):496-503. PubMed ID: 30482480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once-monthly paliperidone palmitate compared with conventional and atypical daily oral antipsychotic treatment in patients with schizophrenia.
    Kim E; Correll CU; Mao L; Starr HL; Alphs L
    CNS Spectr; 2016 Dec; 21(6):466-477. PubMed ID: 27629292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of treatment retention between risperidone long-acting injection, paliperidone palmitate, and aripiprazole once-monthly in elderly patients with schizophrenia.
    Suzuki H; Hibino H
    Psychogeriatrics; 2022 Jan; 22(1):159-160. PubMed ID: 34729877
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and Safety of Paliperidone Palmitate 3-Month Formulation for Patients with Schizophrenia: A Randomized, Multicenter, Double-Blind, Noninferiority Study.
    Savitz AJ; Xu H; Gopal S; Nuamah I; Ravenstijn P; Janik A; Schotte A; Hough D; Fleischhacker WW
    Int J Neuropsychopharmacol; 2016 Jul; 19(7):. PubMed ID: 26902950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aripiprazole Lauroxil Compared with Paliperidone Palmitate in Patients with Schizophrenia: An Indirect Treatment Comparison.
    Cameron C; Zummo J; Desai DN; Drake C; Hutton B; Kotb A; Weiden PJ
    Value Health; 2017; 20(7):876-885. PubMed ID: 28712616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The three-monthly paliperidone palmitate depot in the treatment of schizophrenia].
    Spoelstra SK; Bais L; Knegtering H
    Tijdschr Psychiatr; 2018; 60(12):827-833. PubMed ID: 30536295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population Pharmacokinetics of Paliperidone Palmitate (Once-Monthly Formulation) in Japanese, Korean, and Taiwanese Patients With Schizophrenia.
    Shimizu H; Neyens M; De Meulder M; Gopal S; Tsukamoto Y; Samtani MN; Remmerie B
    Clin Pharmacol Drug Dev; 2020 Feb; 9(2):224-234. PubMed ID: 31876117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interest of clozapine and paliperidone palmitate plasma concentrations to monitor treatment in schizophrenic patients on chronic hemodialysis.
    Samalin L; Lauron S; Llorca PM
    Schizophr Res; 2015 Aug; 166(1-3):351-2. PubMed ID: 25914108
    [No Abstract]   [Full Text] [Related]  

  • 16. Paliperidone Long-Acting Plasma Level Monitoring and a New Method of Evaluation of Clinical Stability.
    Mauri MC; Paletta S; Di Pace C; Reggiori A; Rovera C; Fiorentini A; Altamura CA
    Pharmacopsychiatry; 2017 Jul; 50(4):145-151. PubMed ID: 28278537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paliperidone Palmitate-Induced Retrograde Ejaculation.
    Madan R; Langenfeld RJ; Ramaswamy S
    Clin Schizophr Relat Psychoses; 2018; 12(2):86-88. PubMed ID: 26780600
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationship between response to aripiprazole once-monthly and paliperidone palmitate on work readiness and functioning in schizophrenia: A post-hoc analysis of the QUALIFY study.
    Potkin SG; Loze JY; Forray C; Baker RA; Sapin C; Peters-Strickland T; Beillat M; Nylander AG; Hertel P; Nitschky Schmidt S; Ettrup A; Eramo A; Hansen K; Naber D
    PLoS One; 2017; 12(8):e0183475. PubMed ID: 28837593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery outcomes of schizophrenia patients treated with paliperidone palmitate in a community setting: patient and provider perspectives on recovery.
    Williams W; McKinney C; Martinez L; Benson C
    J Med Econ; 2016; 19(5):469-76. PubMed ID: 26671481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paliperidone and aripiprazole differentially affect the strength of calcium-secretion coupling in female pituitary lactotrophs.
    Kucka M; Tomić M; Bjelobaba I; Stojilkovic SS; Budimirovic DB
    Sci Rep; 2015 Mar; 5():8902. PubMed ID: 25754735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.